A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2
Article in Translational Oncology (April 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
RUVBL1 and RUVBL2 as novel druggable DNA Damage Response regulators in the N-Myc regulatory network in neuroblastoma
Preprint in Research Square (November 2023)
Telomere Attrition With Concomitant hTERT Overexpression Involved in the Progression of Gastric Cancer May Have Prognostic and Clinical Implications in High-Risk Population Group From North India
Article in Frontiers in Oncology (July 2022)